← Open Payments lookup

ZEEV NEMIROVSKY: Open Payments

NPI 1679015747 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,705 in 260 payments from 19 companies in 2025. Trend: 2023 $4,208 · 2024 $3,488 · 2025 $4,705

Food & beverage: $4,612Education: $93
CompanyPaymentsAmount
ABBVIE INC.101$1,571
Janssen Biotech, Inc.25$539
Madrigal Pharmaceuticals20$531
Takeda Pharmaceuticals U.S.A., Inc.19$454
GENZYME CORPORATION19$399
PFIZER INC.17$310
Aimmune Therapeutics, Inc.12$223
Gilead Sciences, Inc.14$173
Ardelyx, Inc.13$148
Ipsen Biopharmaceuticals, Inc4$101

Products named: RINVOQ, TREMFYA, REZDIFFRA, CREON, DUPIXENT, ENTYVIO, SKYRIZI, VELSIPITY.

Industry payments across MD — which companies pay providers there.